Dr Reddys Laboratories (RDY) Total Debt (2009 - 2026)

Dr Reddys Laboratories has reported Total Debt for 18 years, with the latest figure at $813.3 million in Q2 2026.

• On a quarterly basis, Total Debt rose 60.1% year-over-year to $813.3 million in Q2 2026; TTM through Jun 2026 was $813.3 million, a 60.1% increase from a year earlier, with the FY2026 full-year figure at $954.4 million, up 77.73% from the prior year.
• Total Debt was $813.3 million for Q2 2026 at Dr Reddys Laboratories, down from $921.5 million in the prior quarter.
• The five-year high for Total Debt was $921.5 million in Q1 2026, with the low at $105.4 million in Q1 2023.
• Average Total Debt over 5 years is $433.4 million, with a median of $402.0 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Total Debt sank 75.85% in 2023, then surged 253.48% in 2024.
• Over 5 years, Total Debt stood at $229.6 million in 2022, then declined by 3.26% to $222.1 million in 2023, then surged by 166.49% to $591.9 million in 2024, then soared by 34.46% to $795.9 million in 2025, then climbed by 2.18% to $813.3 million in 2026.
• The last three Total Debt figures came in at $813.3 million (Q2 2026), $921.5 million (Q1 2026), and $795.9 million (Q4 2025), per Business Quant data.